Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

6(75.0%)

Phase 3

2(25.0%)

8Total

N/A(6)

Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05669547Not ApplicableCompleted

Dual Hormone Closed Loop in Type 1 Diabetes

Role: collaborator

NCT05738798Not ApplicableEnrolling By Invitation

Oral Immunotherapy in Young Children With Food Allergy

Role: collaborator

NCT05066984Not ApplicableActive Not Recruiting

MONITOR-IC Post ICU Care Study

Role: collaborator

NCT02993315Phase 3Completed

Melanoma Patients Immunized with Natural DenDritic Cells

Role: collaborator

NCT05460793Not ApplicableRecruiting

Dutch Intracerebral Hemorrhage Surgery Trial

Role: collaborator

NCT05318612Phase 3Active Not Recruiting

Effectiveness of MR-guided LITT Therapy in Irresectable Glioblastoma (EMITT)

Role: collaborator

NCT06223295Not ApplicableRecruiting

Effectiveness of Focal Therapy in Men With Prostate Cancer

Role: collaborator

NCT02961582Not ApplicableCompleted

Effectiveness and Cost-effectiveness of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation

Role: collaborator

NCT02961465Completed

Effectiveness and Safety of Sacral Neuromodulation in Patients With Idiopathic Slow-transit Constipation

Role: collaborator

All 9 trials loaded